UK markets closed

NFL Biosciences SA (82F.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.4300+0.1600 (+7.05%)
At close: 08:06AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Cost of revenue
3,478
3,478
2,236
530.733
169.357
-
Gross profit
-3,478
-3,478
-2,236
-530.733
-169.357
-
Operating expenses
Total operating expenses
722.04
722.04
668.956
588.766
148.671
-
Operating income or loss
-4,200
-4,200
-2,905
-1,119
-318.028
-
Interest expense
6.506
6.506
0.493
0.538
0
-
Income before tax
-4,112
-4,112
-2,861
-1,120
-313.044
-
Income tax expense
-366.393
-366.393
-417.829
-141.266
-51.544
-
Income from continuing operations
-3,745
-3,745
-2,443
-978.244
-261.5
-
Net income
-3,745
-3,745
-2,443
-978.243
-261.5
-
Net income available to common shareholders
-3,745
-3,745
-2,443
-978.243
-261.5
-
Basic EPS
-0.54
-
-0.47
-0.19
-0.05
-0.05
Diluted EPS
-0.54
-
-0.47
-0.19
-0.05
-0.05
Basic average shares
7,607
-
5,235
5,235
5,235
5,235
Diluted average shares
7,607
-
5,235
5,235
5,235
5,235